COVID-19 Induced Postural Orthostatic Tachycardia Syndrome (POTS): A Review
- PMID: 37009342
- PMCID: PMC10065129
- DOI: 10.7759/cureus.36955
COVID-19 Induced Postural Orthostatic Tachycardia Syndrome (POTS): A Review
Abstract
POTS (Postural Orthostatic Tachycardia Syndrome) is a multisystem disorder characterized by the abnormal autonomic response to an upright posture, causing orthostatic intolerance and excessive tachycardia without hypotension. Recent reports suggest that a significant percentage of COVID-19 survivors develop POTS within 6 to 8 months of infection. Prominent symptoms of POTS include fatigue, orthostatic intolerance, tachycardia, and cognitive impairment. The exact mechanisms of post-COVID-19 POTS are unclear. Still, different hypotheses have been given, including autoantibody production against autonomic nerve fibers, direct toxic effects of SARS-CoV-2, or sympathetic nervous system stimulation secondary to infection. Physicians should have a high suspicion of POTS in COVID-19 survival when presented with symptoms of autonomic dysfunction and should conduct diagnostic tests like the Tilt table and others to confirm it. The management of COVID-19-related POTS requires a comprehensive approach. Most patients respond to initial non-pharmacological options, but when the symptoms become more severe and they do not respond to the non-pharmacological approach, pharmacological options are considered. We have limited understanding and knowledge of post-COVID-19 POTS, and further research is warranted to improve our understanding and formulate a better management plan.
Keywords: covid-19; covid-19 vaccine; postural orthostatic tachycardia syndrome; pots; sars-cov-2.
Copyright © 2023, Mallick et al.
Conflict of interest statement
The authors have declared that no competing interests exist.
Figures
Similar articles
-
Postural Orthostatic Tachycardia Syndrome Associated with COVID-19: A Narrative Review.Medicina (Kaunas). 2024 Aug 15;60(8):1325. doi: 10.3390/medicina60081325. Medicina (Kaunas). 2024. PMID: 39202605 Free PMC article. Review.
-
Postural orthostatic tachycardia syndrome as a sequela of COVID-19.Heart Rhythm. 2022 Nov;19(11):1880-1889. doi: 10.1016/j.hrthm.2022.07.014. Epub 2022 Jul 16. Heart Rhythm. 2022. PMID: 35853576 Free PMC article. Review.
-
Autonomic dysfunction presenting as postural orthostatic tachycardia syndrome in patients with multiple sclerosis.Int J Med Sci. 2010 Mar 11;7(2):62-7. doi: 10.7150/ijms.7.62. Int J Med Sci. 2010. PMID: 20309394 Free PMC article.
-
Autonomic nervous system dysfunction in adolescents with postural orthostatic tachycardia syndrome and chronic fatigue syndrome is characterized by attenuated vagal baroreflex and potentiated sympathetic vasomotion.Pediatr Res. 2000 Aug;48(2):218-26. doi: 10.1203/00006450-200008000-00016. Pediatr Res. 2000. PMID: 10926298
-
Impact of COVID-19 infection on baseline autonomic symptoms in patients with preexisting postural tachycardia syndrome and orthostatic intolerance: A retrospective study.Am J Med Sci. 2024 May;367(5):323-327. doi: 10.1016/j.amjms.2023.12.011. Epub 2024 Feb 8. Am J Med Sci. 2024. PMID: 38340983
Cited by
-
Autoimmunity in Syndromes of Orthostatic Intolerance: An Updated Review.J Pers Med. 2024 Apr 20;14(4):435. doi: 10.3390/jpm14040435. J Pers Med. 2024. PMID: 38673062 Free PMC article. Review.
-
Postural Orthostatic Tachycardia Syndrome Associated with COVID-19: A Narrative Review.Medicina (Kaunas). 2024 Aug 15;60(8):1325. doi: 10.3390/medicina60081325. Medicina (Kaunas). 2024. PMID: 39202605 Free PMC article. Review.
-
Recovery from Severe COVID-19 Is an Independent Predictor of Electrocardiographic Abnormal P-Wave Axis.Diagnostics (Basel). 2024 Jun 22;14(13):1326. doi: 10.3390/diagnostics14131326. Diagnostics (Basel). 2024. PMID: 39001217 Free PMC article.
-
Post-COVID dysautonomias: what we know and (mainly) what we don't know.Nat Rev Neurol. 2024 Feb;20(2):99-113. doi: 10.1038/s41582-023-00917-9. Epub 2024 Jan 11. Nat Rev Neurol. 2024. PMID: 38212633 Review.
-
A Comprehensive Review of the Global Epidemiology, Clinical Management, Socio-Economic Impacts, and National Responses to Long COVID with Future Research Directions.Diagnostics (Basel). 2024 May 31;14(11):1168. doi: 10.3390/diagnostics14111168. Diagnostics (Basel). 2024. PMID: 38893693 Free PMC article. Review.
References
-
- World Health Organization: WHO coronavirus (COVID-19) dashboard. [ Mar; 2023 ]. 2019. https://covid19.who.int/ https://covid19.who.int/
-
- National Library of Medicine: COVID-19 rapid guideline: managing the long-term effects of COVID-19. [ Mar; 2023 ]. 2020. https://www.ncbi.nlm.nih.gov/books/NBK567261/ https://www.ncbi.nlm.nih.gov/books/NBK567261/ - PubMed
Publication types
LinkOut - more resources
Full Text Sources
Miscellaneous